Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer

Fig. 2

Targeting study. A CLSM images of FITC-labeled Ptb-Lip, Ptb-M-Lip and Ptb-M-Lip-Her uptaken by SK-BR-3 cells. Scale bars: 50 µm. B CLSM images of FITC-labeled Ptb-M-Lip uptaken by SK-BR-3 cells, C6 cells and A549 cells. Scale bars: 50 µm. C The fluorescence intensity of fluorescent images in A. D The fluorescence intensity of fluorescent images in B. E The fluorescence intensity in different organizations. F Tissue fluorescence imaging of FITC-labeled Ptb-Lip, Ptb-M-Lip and Ptb-M-Lip-Her. G Cellular uptake results by SK-BR-3 cells from flow cytometry. All data represented the mean ± SD (n = 3) (*p < 0.05; **p < 0.01; ***p < 0.001)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us